These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 26470032)

  • 1. Increased Tryptophan Catabolism Is Associated With Increased Frequency of CD161+Tc17/MAIT Cells and Lower CD4+ T-Cell Count in HIV-1 Infected Patients on cART After 2 Years of Follow-Up.
    Gaardbo JC; Trøsied M; Stiksrud B; Midttun Ø; Ueland PM; Ullum H; Nielsen SD
    J Acquir Immune Defic Syndr; 2015 Nov; 70(3):228-35. PubMed ID: 26470032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tryptophan catabolism and immune activation in primary and chronic HIV infection.
    Gelpi M; Hartling HJ; Ueland PM; Ullum H; Trøseid M; Nielsen SD
    BMC Infect Dis; 2017 May; 17(1):349. PubMed ID: 28511640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The kynurenine pathway of tryptophan catabolism, CD4+ T-cell recovery, and mortality among HIV-infected Ugandans initiating antiretroviral therapy.
    Byakwaga H; Boum Y; Huang Y; Muzoora C; Kembabazi A; Weiser SD; Bennett J; Cao H; Haberer JE; Deeks SG; Bangsberg DR; McCune JM; Martin JN; Hunt PW
    J Infect Dis; 2014 Aug; 210(3):383-91. PubMed ID: 24585899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reconstitution of intestinal CD4 and Th17 T cells in antiretroviral therapy suppressed HIV-infected subjects: implication for residual immune activation from the results of a clinical trial.
    d'Ettorre G; Baroncelli S; Micci L; Ceccarelli G; Andreotti M; Sharma P; Fanello G; Fiocca F; Cavallari EN; Giustini N; Mallano A; Galluzzo CM; Vella S; Mastroianni CM; Silvestri G; Paiardini M; Vullo V
    PLoS One; 2014; 9(10):e109791. PubMed ID: 25340778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination antiretroviral therapy with raltegravir leads to rapid immunologic reconstitution in treatment-naive patients with chronic HIV infection.
    Pallikkuth S; Fischl MA; Pahwa S
    J Infect Dis; 2013 Nov; 208(10):1613-23. PubMed ID: 23922374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection.
    Jenabian MA; El-Far M; Vyboh K; Kema I; Costiniuk CT; Thomas R; Baril JG; LeBlanc R; Kanagaratham C; Radzioch D; Allam O; Ahmad A; Lebouché B; Tremblay C; Ancuta P; Routy JP;
    J Infect Dis; 2015 Aug; 212(3):355-66. PubMed ID: 25616404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory T cells in HIV-infected immunological nonresponders are increased in blood but depleted in lymphoid tissue and predict immunological reconstitution.
    Gaardbo JC; Hartling HJ; Ronit A; Springborg K; Gjerdrum LM; Ralfkiær E; Thorsteinsson K; Ullum H; Andersen ÅB; Nielsen SD
    J Acquir Immune Defic Syndr; 2014 Aug; 66(4):349-57. PubMed ID: 24784764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed loss of control of plasma lipopolysaccharide levels after therapy interruption in chronically HIV-1-infected patients.
    Papasavvas E; Pistilli M; Reynolds G; Bucki R; Azzoni L; Chehimi J; Janmey PA; DiNubile MJ; Ondercin J; Kostman JR; Mounzer KC; Montaner LJ
    AIDS; 2009 Jan; 23(3):369-75. PubMed ID: 19114856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma IP-10 Is Increased in Immunological NonResponders and Associated With Activated Regulatory T Cells and Persisting Low CD4 Counts.
    Stiksrud B; Lorvik KB; Kvale D; Mollnes TE; Ueland PM; Trøseid M; Taskén K; Dyrhol-Riise AM
    J Acquir Immune Defic Syndr; 2016 Oct; 73(2):138-48. PubMed ID: 27632144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection.
    Zangerle R; Widner B; Quirchmair G; Neurauter G; Sarcletti M; Fuchs D
    Clin Immunol; 2002 Sep; 104(3):242-7. PubMed ID: 12217334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atorvastatin reduces T-cell activation and exhaustion among HIV-infected cART-treated suboptimal immune responders in Uganda: a randomised crossover placebo-controlled trial.
    Nakanjako D; Ssinabulya I; Nabatanzi R; Bayigga L; Kiragga A; Joloba M; Kaleebu P; Kambugu AD; Kamya MR; Sekaly R; Elliott A; Mayanja-Kizza H
    Trop Med Int Health; 2015 Mar; 20(3):380-90. PubMed ID: 25441397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD161+ MAIT cells are severely reduced in peripheral blood and lymph nodes of HIV-infected individuals independently of disease progression.
    Eberhard JM; Hartjen P; Kummer S; Schmidt RE; Bockhorn M; Lehmann C; Balagopal A; Hauber J; van Lunzen J; Schulze zur Wiesch J
    PLoS One; 2014; 9(11):e111323. PubMed ID: 25369333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of aprepitant on kynurenine to tryptophan ratio in cART treated and cART naïve adults living with HIV.
    Spitsin S; Pappa V; Kinder A; Evans DL; Rappaport J; Douglas SD
    Medicine (Baltimore); 2021 Jun; 100(23):e25313. PubMed ID: 34114978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naïve/Effector CD4 T cell ratio as a useful predictive marker of immune reconstitution in late presenter HIV patients: A multicenter study.
    Bordoni V; Brando B; Piselli P; Forini O; Perna FE; Atripaldi U; Carputo S; Garziano F; Trento E; D'Agosto G; Latini A; Colafigli M; Cristaudo A; Sacchi A; Andreoni M; De Carli G; Orchi N; Grelli S; Gatti A; Cerva C; Minutolo A; Potestà M; Di Martino ML; Ortu F; Selva P; Del Pup L; Guarnori I; Lorenzini P; Capuano G; Antinori A; Agrati C
    PLoS One; 2019; 14(12):e0225415. PubMed ID: 31869342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-retroviral therapy decreases but does not normalize indoleamine 2,3-dioxygenase activity in HIV-infected patients.
    Chen J; Shao J; Cai R; Shen Y; Zhang R; Liu L; Qi T; Lu H
    PLoS One; 2014; 9(7):e100446. PubMed ID: 24983463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease.
    Favre D; Mold J; Hunt PW; Kanwar B; Loke P; Seu L; Barbour JD; Lowe MM; Jayawardene A; Aweeka F; Huang Y; Douek DC; Brenchley JM; Martin JN; Hecht FM; Deeks SG; McCune JM
    Sci Transl Med; 2010 May; 2(32):32ra36. PubMed ID: 20484731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between different methods to measure microbial translocation and its association with immune activation in long-term suppressed HIV-1-infected individuals.
    Abad-Fernández M; Vallejo A; Hernández-Novoa B; Díaz L; Gutiérrez C; Madrid N; Muñoz MA; Moreno S
    J Acquir Immune Defic Syndr; 2013 Oct; 64(2):149-53. PubMed ID: 24047967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markers of T Cell Exhaustion and Senescence and Their Relationship to Plasma TGF-β Levels in Treated HIV+ Immune Non-responders.
    Shive CL; Freeman ML; Younes SA; Kowal CM; Canaday DH; Rodriguez B; Lederman MM; Anthony DD
    Front Immunol; 2021; 12():638010. PubMed ID: 33868264
    [No Abstract]   [Full Text] [Related]  

  • 19. HIV-Specific CD8 T Cells Producing CCL-4 Are Associated With Worse Immune Reconstitution During Chronic Infection.
    Casetti R; Pinnetti C; Sacchi A; De Simone G; Bordoni V; Cimini E; Tumino N; Besi F; Viola D; Turchi F; Mazzotta V; Antinori A; Martini F; Ammassari A; Agrati C
    J Acquir Immune Defic Syndr; 2017 Jul; 75(3):338-344. PubMed ID: 28418988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major influence of CD4 count at the initiation of cART on viral and immunological reservoir constitution in HIV-1 infected patients.
    Depincé-Berger AE; Vergnon-Miszczycha D; Girard A; Frésard A; Botelho-Nevers E; Lambert C; Del Tedesco E; Genin C; Pozzetto B; Lucht F; Roblin X; Bourlet T; Paul S
    Retrovirology; 2016 Jun; 13(1):44. PubMed ID: 27363286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.